These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32861280)

  • 1. What Is Responsible for Heterogeneity in Mantle Cell Lymphoma Biology and Outcomes?
    Witzig TE
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):825-835. PubMed ID: 32861280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities.
    Chinen Y; Tsukamoto T; Maegawa-Matsui S; Matsumura-Kimoto Y; Takimoto-Shimomura T; Tanba K; Mizuno Y; Fujibayashi Y; Kuwahara-Ota S; Shimura Y; Kobayashi T; Horiike S; Taniwaki M; Kuroda J
    Exp Hematol; 2020 Apr; 84():45-53.e1. PubMed ID: 32145384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous mantle cell lymphoma histomorphologically mimicking subcutaneous panniculitis-like T-cell lymphoma: Case report.
    Laggis C; Miles R; Stephens DM; Duffy K; Bowen A; Wada D
    J Cutan Pathol; 2019 Jul; 46(7):538-541. PubMed ID: 30957249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite mantle-cell lymphoma and classical Hodgkin lymphoma.
    Hayes SJ; Banerjee SS; Cook Y; Houghton JB; Menasce LP
    Histopathology; 2006 Apr; 48(5):621-3. PubMed ID: 16623796
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular pathogenesis of mantle cell lymphoma.
    Jares P; Colomer D; Campo E
    J Clin Invest; 2012 Oct; 122(10):3416-23. PubMed ID: 23023712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One translocation for 2 lymphoid neoplasms.
    Aussedat G; Baseggio L
    Blood; 2019 Jan; 133(2):180. PubMed ID: 30630847
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunophenotypic and genetic characterization of a CD8 positive mantle cell lymphoma in a patient with concomitant Mycosis fungoides.
    Schroers R; Hildebrandt Y; Steffens R; Becker S; Ohms G; von Bonin F; Haase D; Bertsch HP; Trümper L; Griesinger F
    Eur J Haematol; 2005 Jul; 75(1):78-84. PubMed ID: 15946316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoform.
    Iaccarino I; Afify L; Aukema SM; Reddemann K; Schütt P; Flür M; Klapper W
    Haematologica; 2018 Sep; 103(9):e432-e435. PubMed ID: 29773591
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of preclinical manifestations of mantle cell lymphoma and mantle cell lymphoma in situ in reactive lymphoid tissues.
    Adam P; Schiefer AI; Prill S; Henopp T; Quintanilla-Martínez L; Bösmüller HC; Chott A; Fend F
    Mod Pathol; 2012 Dec; 25(12):1629-36. PubMed ID: 22790016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis.
    Quintanilla-Martinez L; Davies-Hill T; Fend F; Calzada-Wack J; Sorbara L; Campo E; Jaffe ES; Raffeld M
    Blood; 2003 Apr; 101(8):3181-7. PubMed ID: 12515730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma.
    Drexler HG; MacLeod RA
    Leuk Res; 2002 Sep; 26(9):781-7. PubMed ID: 12127550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the assessment of minimal residual disease in mantle cell lymphoma.
    Jung D; Jain P; Yao Y; Wang M
    J Hematol Oncol; 2020 Sep; 13(1):127. PubMed ID: 32972438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flipping the cyclin D1 switch in mantle cell lymphoma.
    Hasanali Z; Sharma K; Epner E
    Best Pract Res Clin Haematol; 2012 Jun; 25(2):143-52. PubMed ID: 22687450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected.
    Stefancikova L; Moulis M; Fabian P; Falkova I; Vasova I; Kren L; Macak J; Smardova J
    J Clin Pathol; 2009 Oct; 62(10):948-50. PubMed ID: 19783727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
    Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
    Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pitfalls and update in haematopathology. Case 2. "Early phase" mantle cell lymphoma of the lymph node].
    Copie-Bergman C
    Ann Pathol; 2012 Oct; 32(5):336-40. PubMed ID: 23141941
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of 4 mantle cell lymphoma cell lines.
    Amin HM; McDonnell TJ; Medeiros LJ; Rassidakis GZ; Leventaki V; O'Connor SL; Keating MJ; Lai R
    Arch Pathol Lab Med; 2003 Apr; 127(4):424-31. PubMed ID: 12683869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of a new mantle cell lymphoma cell line M-1.
    Goy A; Remache YK; Gu J; Stewart J; Hayes KJ; Gold D; Jiang Y; Barkoh BA; Katz R; Cabanillas F; Gilles F
    Leuk Lymphoma; 2004 Jun; 45(6):1255-60. PubMed ID: 15360009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current treatment standards and emerging strategies in mantle cell lymphoma.
    Dreyling M; Hiddemann W;
    Hematology Am Soc Hematol Educ Program; 2009; ():542-51. PubMed ID: 20008239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.